The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product…
Active Awarded Last action
- Contract number
- 75N93021D00010
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 6 $1,229,739 obligated
Award facts
- Opportunity
-
- Preclinical Services for HIV Therapeutics Pre-Solicitation · 75N93019R00021 · Posted Oct 4, 2019
- Preclinical Services for HIV Therapeutics Award Notice · Posted Oct 20, 2020
- Preclinical Services for HIV Therapeutics Solicitation · Posted Dec 5, 2019
- Combined order value
-
- $1,229,739 Current, with exercised options
- $1,471,701 Potential, with all options
- Last date to order 86% complete
- IDV ceiling 1% used
- $107,274,471.00
- Maximum order
- $107,274,471.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $107,274,471 Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Southern Research Institute, a non-profit research organization, to provide preclinical development support for candidate products and drug development activities related to HIV therapeutics. The contract does not have a set-aside designation and has a period of performance through October 14, 2027.
Under this IDIQ, Southern Research Institute will perform a range of tasks through individual delivery orders, including in vitro testing and screening, synthesis of therapeutic agents, development of small animal models, formulation development, preclinical pharmacology and toxicology studies, and a reagent program to support basic and translational research for HIV and other infectious diseases. These contracted services aim to help investigators obtain critical data and materials to advance promising drug candidates from the bench to the clinic.
Description
The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product discovery to those required to support clinical trials and/o
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93021D00010?
75N93021D00010 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.
How much is contract 75N93021D00010 worth?
Orders under 75N93021D00010 have obligated $1,229,739. Their combined potential value, with all options, is $1,471,701. 75N93021D00010's own ceiling is $107,274,471. A single order can be worth up to $107,274,471.
How many orders have been placed under contract 75N93021D00010?
6 orders have been placed under 75N93021D00010, the latest on July 1, 2024.
Who can order from contract 75N93021D00010?
75N93021D00010 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93021D00010 part of a contract vehicle?
Yes. 75N93021D00010 is part of Preclinical Services for HIV Therapeutics.
Was contract 75N93021D00010 competed?
The extent of competition for 75N93021D00010 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV